Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
MindMed Reports First Quarter 2024 Financial Results and Business Updates
8 May 24
424B3
Prospectus supplement
30 Apr 24
424B3
Prospectus supplement
30 Apr 24
EFFECT
Notice of effectiveness
30 Apr 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
S-3
Shelf registration
2 Apr 24
8-K
MindMed Announces Voluntary Delisting from Cboe Canada
1 Apr 24
D
$75.00 mm in equity, sold $75.00 mm, 2 investors
18 Mar 24
8-K
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
11 Mar 24
424B5
Prospectus supplement for primary offering
7 Mar 24
8-K
Regulation FD Disclosure
7 Mar 24
S-3MEF
Registration of additional securities for an S-3
7 Mar 24
8-K
Mindmed Receives Fda Breakthrough Therapy Designation
7 Mar 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
MindMed Reports 2023 Financial Results and Business Updates
28 Feb 24
8-K
MindMed Announces Business Update and Anticipated Milestones for 2024
8 Jan 24
8-K
MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120
14 Dec 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
MindMed Reports Third Quarter 2023 Financial Results and Business Highlights
2 Nov 23
8-K/A
Other Events
15 Sep 23
8-K/A
Other Events
15 Sep 23
8-K
Company Logo MindMed Investor Presentation August 2023
14 Aug 23
8-K
Entry into a Material Definitive Agreement
14 Aug 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
MindMed Reports Second Quarter 2023 Financial Results and Business Highlights
3 Aug 23
8-K/A
Submission of Matters to a Vote of Security Holders
25 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
27 Jun 23
8-K
Regulation FD Disclosure
20 Jun 23
DEFA14A
Additional proxy soliciting materials
16 Jun 23
8-K
Other Events
16 Jun 23
DFAN14A
Additional proxy materials by non-management
16 Jun 23
DFAN14A
Additional proxy materials by non-management
15 Jun 23
8-K
MindMed Adjourns Annual General Meeting of Shareholders
15 Jun 23
DEFA14A
Additional proxy soliciting materials
15 Jun 23
DFAN14A
Additional proxy materials by non-management
12 Jun 23
DEFA14A
Additional proxy soliciting materials
12 Jun 23
DFAN14A
Additional proxy materials by non-management
9 Jun 23
Latest ownership filings
4
Schond L. Greenway
26 Mar 24
4
Dan Karlin
26 Mar 24
4
Robert Barrow
26 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
SC 13G
COMMODORE CAPITAL LP
21 Mar 24
SC 13G
Deep Track Capital, LP
15 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
Miri Halperin Wernli
29 Feb 24
4
Schond L. Greenway
29 Feb 24
4
Mark Sullivan
29 Feb 24
4
Dan Karlin
29 Feb 24
4
Carrie Liao
29 Feb 24
4
Robert Barrow
29 Feb 24
4
Dan Karlin
26 Dec 23
4
Robert Barrow
26 Dec 23
4
Schond L. Greenway
26 Dec 23
144
Notice of proposed sale of securities
26 Dec 23
144
Notice of proposed sale of securities
26 Dec 23
144
Notice of proposed sale of securities
26 Dec 23
4
Robert Barrow
25 Sep 23
4
Dan Karlin
25 Sep 23
4
Schond L. Greenway
25 Sep 23
144
Notice of proposed sale of securities
25 Sep 23
144
Notice of proposed sale of securities
25 Sep 23
144
Notice of proposed sale of securities
25 Sep 23
4
Schond L. Greenway
28 Aug 23
144
Notice of proposed sale of securities
28 Aug 23
144
Notice of proposed sale of securities
28 Aug 23
4
Robert Barrow
27 Jun 23
4
Dan Karlin
27 Jun 23
4
Schond L. Greenway
27 Jun 23
4
DAVID W GRYSKA
23 Jun 23
4
ROGER CRYSTAL
23 Jun 23
4
Andreas Krebs
23 Jun 23
4
Carol A Vallone
23 Jun 23
4
Suzanne Louise Bruhn
23 Jun 23
3
DAVID W GRYSKA
23 Jun 23
4/A
Schond L. Greenway
24 Apr 23
4/A
Miri Halperin Wernli
24 Apr 23